All News

My Dad’s Death From Cancer Forced Me Out of the Shadows and Into a Spotlight of Advocacy

January 31st 2022

A teenager from Pennsylvania whose father died from colorectal cancer explains the impact it had on her life and how she has stepped into the field of advocacy to help others.

Momelotinib ‘Stands On Its Own’ Compared With Other JAK Inhibitors for Myelofibrosis

January 31st 2022

For patients with myelofibrosis, previously treated with Jakafi, momelotinib could be a major drug approval coming up, according to an expert.

Moving on From a Mindset of Life Around Cancer Scans

January 30th 2022

A cancer survivor explains how he has learned to build resilience against the stress and terror around getting routine cancer scans done so that he can live his life more freely.

Soul Survivor: How One Breast Medical Oncologist’s Personal Experience With Surviving Cancer Influenced Her Patient Care

January 30th 2022

A colleague writes about a medical oncologist who has a rare metastatic breast cancer diagnosis but still manages to go above and beyond for her patients while dealing with her own cancer treatments, and how her empathy guides her.

When COVID-19 Cancels Your Cancer Appointments: Why Are We Still in Crisis Mode 2 Years Later?

January 29th 2022

A colon cancer survivor expresses her frustration about the way the health care system is currently being managed as yet another wave of COVID-19 cases caused her to cancel an appointment she’d waited three months for.

We Don’t Need More Pink Ribbons for Breast Cancer — We Need Treatments and Hope

January 29th 2022

A mother writes about her daughter — a nurse with metastatic breast cancer who passionately cares for patients even while undergoing chemotherapy — and how more treatment options are desperately needed.

Limiting Alcohol Consumption During Cancer Treatment May Improve Health, Lessen Risk for Additional Diagnoses

January 28th 2022

Patients who limit alcohol intake during their cancer treatment may experience several health benefits, according to physicians from Tampa Bay Radiation Oncology.

Skin-Related Side Effects From a Certain Cancer Treatment May Indicate Stronger Responses, Survival

January 28th 2022

Side effects from cancer treatment with immunotherapy, which may include vitiligo and certain rashes, may point to who will respond better to the treatment, although more research is needed to determine how much weight to put on these data.

I Survived Cancer and Now COVID-19. Here’s What I Learned

January 28th 2022

A man with breast cancer explains how contracting COVID-19 led him to discovering the benefits of slowing down.

‘Seinfeld’ Actress Kathryn Kates Dies From Cancer, Rower With Cancer Breaks Transatlantic Record

January 28th 2022

From the lung cancer death of “Seinfeld” actress Kathryn Kates to a patient with cancer who broke a rowing world record, here’s what’s happening in the cancer landscape this week.

FDA Halts Several Studies Examining Magrolimab-Onureg Combo Across Multiple Cancer Types Due to Serious Side Effects

January 28th 2022

All clinical trials investigating the combination of magrolimab and the chemotherapy Onureg have been paused due to unforeseen serious side effects experienced by patients with various blood cancers receiving the treatment.

New Drug Combination May Improve Outcomes in Unresectable Liver Cancer

January 27th 2022

An expert from Memorial Sloan Kettering Cancer Center in New York discusses the promising findings from a study that analyzed tremelimumab plus Imfinzi for unresectable hepatocellular carcinoma, and outlines side effects patients should discuss with their doctor.

Combination Therapy for Advanced Kidney Cancer Subtype May Lead Patients to Live Longer, Better Lives

January 27th 2022

Opdivo plus Cabometyx prolonged survival with minimal effects to their health status, which may highlight the need for patients to advocate for their quality of life when making treatment decisions.

Knowledge Is Power: How NBC’s ‘The More You Know’ Influenced My Cancer Experience

January 27th 2022

A breast cancer survivor discusses how researching cancer risks and environmental factors made her feel better equipped with information against the disease.

‘Let’s Go After This Thing and Fight’ Urges a Long-Time Survivor of Early-Onset CRC

January 27th 2022

In this episode of the “Cancer Horizons” podcast, a woman living with colorectal cancer who was diagnosed 14 years ago at age 29 discusses what it was like to be the youngest person in the treatment room, and how she found another community of young survivors.

First Allogeneic RNA Cell Therapy Clinical Trial Begins in Multiple Myeloma

January 27th 2022

A clinical trial to evaluate Descartes-25, a novel allogeneic RNA cell therapy, for multiple myeloma has officially treated its first patient and is now recruiting in certain locations.

Adagrasib Confers High Response Rates in Several Gastrointestinal, Pancreatic Tumors

January 26th 2022

Single-agent adagrasib was associated with encouraging treatment responses in patients with previously treated non-colorectal gastrointestinal tumors and pancreatic ductal adenocarcinoma.

Oral Antimetabolite After Surgery Associated With Survival Benefit in Biliary Tract Cancer

January 26th 2022

Patients with biliary tract cancer achieved a better survival outcome after receiving treatment with an oral antimetabolite following surgical resection than patients who only were treated with surgery.

My Experience Enrolling in a Cancer Clinical Trial: The Verdict Is ‘Yes’

January 26th 2022

A patient with ovarian cancer describes how she enrolled in a clinical trial, and how it has given her a renewed sense of hope that she may find a successful treatment option.

‘Life Is Never the Same Again’: Cancer Survivors Describe the Most Difficult Elements of Survivorship

January 26th 2022

From mental impacts such as “scanxiety” and post-traumatic stress disorder to difficulties returning to work/dating and long-term physical side effects like memory issues, several cancer survivors shared the hardest part about survivorship.

FDA Approves Kimmtrak for Unresectable or Metastatic Uveal Melanoma

January 26th 2022

Kimmtrak is the first-ever drug to be granted FDA approval for this patient population of HLA-A*02:01-positive metastatic or unresectable uveal melanoma.

Cosibelimab Elicits Positive Tumor Response in Patients With Metastatic Skin Cancer Subtype

January 25th 2022

Patients with metastatic cutaneous squamous cell carcinoma achieved promising response rates after treatment with cosibelimab. If approved, drug developers are hoping to offer cosibelimab as a more affordable immunotherapy option for this patient population.

For Better and for Worse: How the COVID-19 Pandemic Changed Cancer Care

January 25th 2022

The COVID-19 pandemic drastically impacted many facets of cancer care. Although some changes were detrimental, an expert from Johns Hopkins Medicine notes others actually improved accessibility to care.

‘Let’s Take the Stairs:’ How I Encouraged My Daughter to Get Exercise During Cancer Treatments

January 25th 2022

A mother of a breast cancer survivor explains how she and her daughter creatively incorporated exercise into her daughter’s daily routine to improve her physical and mental health during treatment.

Keytruda Plus Mektovi and Avastin Associated With Survival Benefit in Metastatic Colon Cancer

January 25th 2022

A group of patients with microsatellite-stable, treatment-refractory metastatic colorectal cancer experienced responses to treatment with Keytruda plus Mektovi and Avastin.

Blood Test Results May Identify Which Patients With CRC May Benefit From Post-Surgical Chemotherapy

January 25th 2022

The use of a ctDNA assay could help determine which patients with colorectal cancer may benefit most from chemotherapy after surgery.

VHL-Related Kidney Cancer Survivor Reflects on Decades of Change for the Rare Condition

January 24th 2022

When Joseph Heisler was diagnosed with von Hippel-Lindau disease 30 years ago, there was hardly any information on the condition. Fast forward three decades, there is an FDA-approved drug and a handbook of information available in two languages.

Kymriah Shows ‘Huge Potential’ for Patients With Heavily Pretreated, Relapsed Follicular Lymphoma

January 24th 2022

Kymriah may represent a more effective option than currently available treatments for patients with heavily pretreated follicular lymphoma, according to an expert from The University of Texas MD Anderson Cancer Center.

Support From Beyond: How My Deceased Loved Ones Helped Me Navigate My Cancer Journey

January 24th 2022

A survivor of multiple cancers explains how “visits” from deceased friends and loved ones made her feel safe before undergoing treatments.

Gut Microbiome Makeup May Help Predict Skin-Related Immunotherapy Side Effects in Patients With Gastric Cancer

January 24th 2022

Patients with gastric cancer who present with certain bacteria in their gut were found to be more likely to experience skin-related side effects from Opdivo treatment, research showed.